DIA Biosimilars 2013

etrials Worldwide

eTrials Names Permanent CFO

Wednesday, September 17, 2008 04:00 PM

etrials, a Morrisville, NC-based eClinical company, named Joseph (Jay) Trepanier II permanent secretary and CFO, replacing James Clark, who resigned in May. Trepanier had been serving as interim secretary and CFO since May and had previously been etrials’ corporate controller and vice president of finance. etrials is currently in the midst of a CEO search, following the sudden resignation of Eugene Chip” Jennings in July. Vice president of technology Chuck Piccirillo serves as interim CEO.

More... »

Cenduit: Now with Patient Reminders

etrials 2nd Quarter Earnings Reflect Ongoing Financial Woes

Friday, August 15, 2008 06:00 AM

Just a month after etrials lost yet another key executive, the eClinical company released 2nd quarter numbers that illustrate the company’s ongoing struggles.

More... »

CRF Health – eCOA Forum

etrials CEO Chip Jennings Steps Down

Tuesday, July 15, 2008 12:42 PM

Adding to etrials’ ongoing financial woes and a recent flurry of senior management changes, Eugene "Chip" Jennings, CEO at the Morrisville, N.C.-based eClinical company, unexpectedly resigned his post, citing “family reasons.” Jennings was CEO for a little more than a year, replacing John Cline founder and former CEO who resigned in May 2007.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs